Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Binder

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Current Medical Research and Opinion|March 19, 2015
Patterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myelomaSteven R Arikian, Dejan Milentijevic, Gary Binder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic ChemotherapyEric J Roeland, Kathryn J Ruddy, Thomas W LeBlanc, et al.
JCO Oncology Practice|December 5, 2019
Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute CareRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
The Oncologist|December 17, 2022
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later CyclesRudolph Navari, Gary Binder, Alex Molasiotis, et al.
The Oncologist|December 8, 2020
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or OxaliplatinRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxisLee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, et al.
Journal of the American Heart Association|May 9, 2023
Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection FractionJosephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Medical Research and Opinion|March 19, 2015
Patterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myelomaSteven R Arikian, Dejan Milentijevic, Gary Binder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic ChemotherapyEric J Roeland, Kathryn J Ruddy, Thomas W LeBlanc, et al.
JCO Oncology Practice|December 5, 2019
Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute CareRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
The Oncologist|December 17, 2022
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later CyclesRudolph Navari, Gary Binder, Alex Molasiotis, et al.
The Oncologist|December 8, 2020
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or OxaliplatinRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxisLee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy, et al.
Journal of the American Heart Association|May 9, 2023
Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection FractionJosephine Harrington, Jie-Lena Sun, Gregg C Fonarow, et al.
Pageof 2